Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4786-52-1 | MDL No. : | MFCD00194922 |
Formula : | C7H8N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PLMIZYMXBHSARX-UHFFFAOYSA-N |
M.W : | 168.15 | Pubchem ID : | 96347 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 40.94 |
TPSA : | 72.05 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.52 cm/s |
Log Po/w (iLOGP) : | 1.06 |
Log Po/w (XLOGP3) : | -0.28 |
Log Po/w (WLOGP) : | -0.05 |
Log Po/w (MLOGP) : | -0.22 |
Log Po/w (SILICOS-IT) : | 1.18 |
Consensus Log Po/w : | 0.34 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.88 |
Solubility : | 22.3 mg/ml ; 0.132 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.77 |
Solubility : | 28.3 mg/ml ; 0.168 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.03 |
Solubility : | 1.55 mg/ml ; 0.00925 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With thionyl chloride In tetrahydrofuran for 4 h; Heating / reflux | Ethyl 4-hydroxypyrimidine-5-carboxylate (380 mg, 2.26 mmol) was dissolved in THF (5 mL) and treated with thionyl chloride (1.65 ml, 22.6 mmol). The solution was heated to reflux for 4 h and then concentrated in vacuo, yielding 417 mg (99percent) of the crude product. This material was used without purification or characterization. |
99% | With thionyl chloride In tetrahydrofuran for 4 h; Heating / reflux | Ethyl 4-hydroxypyπmιdιne-5-carboxylate (380 mg, 2.26 mmol) was dissolved in THF (5 mL) and treated with thionyl chloride (1.65 ml, 22.6 mmol). The solution was heated to reflux for 4 h and then concentrated in vacuo, yielding 417 mg (99percent) of the crude product This material was used without purification or characterization |
99% | With thionyl chloride In tetrahydrofuran for 4 h; Heating / reflux | Ethyl 4-hydroxypyrimidine-5-carboxylate (380 mg, 2.26 mmol) was dissolved in THF (5 mL) and treated with thionyl chloride (1.65 ml, 22.6 mmol). The solution was heated to reflux for 4 h and then concentrated in vacuo, yielding 417 mg (99percent) of the crude product. This material was used without purification or characterization. |
95% | at 120℃; for 5 h; | 2 g of the compound obtained in step 1) above was dissolved in 3.5 mL of phosphorus oxychloride, and 18 mL of thionylchloride and 50 \\ih of dimethylformamide were added thereto. The mixture was stirred at 120°C under reflux for 5 hours. After the reaction was completed, the reaction mixture was distilled under a reduced pressure. 50 mL of toluene was added to the residue, the resulting residue was distilled under a reduced pressure (repeated twice) and the resulting solid was dried to obtain the title compound (2.1 g, yield: 95percent).1H-NMR (300MHz, DMSO-d6) δ 9.18 (s, 2H), 4.36 {dd, 2H), 1.33 (t, 3H). |
77% | With N-ethyl-N,N-diisopropylamine; trichlorophosphate In toluene at 70℃; for 2 h; | To a suspension of ethyl 4-hydroxy-pyrimidine-5-carboxylate (3.0g, 17.6 mmol) in toluene (35ml) was added diisopropylethylamine (3.4 ml, 19.6mmol) and phosphorous oxychloride (1.8 ml, 19.6 mmol) dropwise under a nitrogen atmosphere. The reaction mixture was heated to 700C, and stirred for two hours then cooled to 5°C. A IM aqueous solution of sodium hydroxide (26 ml) was added and the mixture was diluted with water and extracted into ethyl acetate. The organic layer was washed with water, saturated sodium hydrogencarbonate, then dried over sodium sulfate, filtered and concentrated to give the title compound as a brown oil (2.56g, 77percent). 1H NMR (CDCl3, 400 MHz) 9.13 (s, IH), 9.08 (s, IH), 4.47 (q, J = 6.9 Hz, 2H), 1.44 (t, J = 6.9 Hz, 3H). |
[ 65754-04-3 ]
6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid
Similarity: 0.92
[ 67383-32-8 ]
Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate
Similarity: 0.91
[ 53554-29-3 ]
Ethyl 2-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxylate
Similarity: 0.79
[ 313535-84-1 ]
Methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate
Similarity: 0.68
[ 155960-91-1 ]
Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate
Similarity: 0.65
[ 67383-32-8 ]
Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate
Similarity: 0.91
[ 53554-29-3 ]
Ethyl 2-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxylate
Similarity: 0.79
[ 313535-84-1 ]
Methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate
Similarity: 0.68
[ 155960-91-1 ]
Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate
Similarity: 0.65
[ 42821-92-1 ]
Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
Similarity: 0.63
[ 65754-04-3 ]
6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid
Similarity: 0.92
[ 67383-32-8 ]
Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate
Similarity: 0.91
[ 53554-29-3 ]
Ethyl 2-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxylate
Similarity: 0.79
[ 42821-92-1 ]
Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
Similarity: 0.63
[ 65195-35-9 ]
Ethyl 4-aminopyrimidine-5-carboxylate
Similarity: 0.61